Andrew Buda MD


Andrew Buda MDProfessor of  Medicine- Cardiovascular Medicine






Dr. Andrew Buda has previously had 13 years of continuous NIH funding studying left ventricular function, myocardial flow-function relationships, and pathophysiologic mechanisms of myocardial ischemic-reperfusion injury. Current research efforts are clinically focused in the area of heart failure.


  • Buda AJ, Pinsky MR, Ingels GB, Daughters GT, Stinson EB, Alderman EL: Effects of intrathoracic pressure on left ventricular performance. New England Journal of Medicine 301:453-459, 1979
  • Fung AY, Gallagher KP, Buda AJ: The physiologic basis of dobutamine versus dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation 76:943-951, 1987
  • Lefer DJ, Flynn DM, Phillips ML, Radcliffe M, Buda AJ: A novel Sialyl Lewis-x analog attenuates neutrophil accumulation and myocardial necrosis following ischemia and reperfusion. Circulation 90:2390-2401, 1994
  • Lockyer JM, Colladay JS, Alperin-Lea WL, Buda AJ: Inhibition of NF-kappa-B mediated adhesion molecule expression in human endothelial cells. Circulation Research 82:314-320, 1998
  • Okello S, Abeya FC, Lumori B, Moore CC, Annex BH, Buda AJ: Validation of heart failure quality of life tool and usage to predict all cause mortality in acute heart failure in Uganda: The Mbarara Heart Failure Registry (MAHFER). BMC Cardiovascular Disord. 2018 Dec12;18(1):232 doi:10.1186/s12872-018-0959-1